CD2AP and central nervous system cancer: To further verify the involvement of CD2AP in GBM, we compared CD2AP levels between HEB cells and various glioma cell lines (SHG44, U87MG, and U251) and found that CD2AP levels were higher in glioma cells than in HEB cells (Fig. 1H, I).